{"id":48831,"date":"2022-09-26T22:02:05","date_gmt":"2022-09-26T20:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/"},"modified":"2022-09-26T22:02:05","modified_gmt":"2022-09-26T20:02:05","slug":"idex-corporation-to-webcast-third-quarter-2022-earnings-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/","title":{"rendered":"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call"},"content":{"rendered":"
\n

NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company\u2019s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company\u2019s third quarter 2022 financial performance and respond to questions from the financial community.\n<\/p>\n

<\/a><\/p>\n

\nIDEX invites interested investors to listen to the call and view the presentation slides, which will be available on its website: www.idexcorp.com<\/a>. To hear the live call, log on to the site several minutes before the discussion begins. After clicking on the presentation icon, follow the instructions to ensure your system is set up for the event, or download the correct applications at no charge. An archive of the webcast will be available through the IDEX website after the call. An audio replay of the call is also available through midnight, November 26, 2022 by dialing 877.660.6853 or (201.612.7415) for international participants using conference code # 13724805\n<\/p>\n

\nAbout IDEX<\/span><\/b>\n<\/p>\n

\nIDEX (NYSE: IEX) is a company that has undoubtedly touched your life in some way. In fact, IDEX businesses make thousands of products that are mission-critical components in everyday activities. Chances are the car you\u2019re driving has a BAND-IT\u00ae clamp holding your side airbag safely in place. If you were ever in a car accident, a Hurst Jaws of Life\u00ae rescue tool may have saved your life. If you or a family member is battling cancer, your doctor may have tested your DNA in a quest to find the best targeted medicine for you. It\u2019s likely your DNA test was run on equipment that contains components made by our IDEX Health & Science team. Founded in 1988 with three small, entrepreneurial manufacturing companies, we\u2019re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 8,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol \u201cIEX\u201d.\n<\/p>\n

\nFor further information on IDEX Corporation and its business units, visit the company\u2019s website at www.idexcorp.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nIDEX Corporation
\n
Allison Lausas
\n
Chief Accounting Officer
\n
847.498.7070\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company\u2019s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company\u2019s third … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48831","6":"format-standard","7":"category-industry"},"yoast_head":"\nIDEX Corporation to Webcast Third Quarter 2022 Earnings Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company\u2019s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company\u2019s third ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-26T20:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220926005789\/en\/1160297\/21\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call\",\"datePublished\":\"2022-09-26T20:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/\"},\"wordCount\":398,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220926005789\\\/en\\\/1160297\\\/21\\\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/\",\"name\":\"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220926005789\\\/en\\\/1160297\\\/21\\\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg\",\"datePublished\":\"2022-09-26T20:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220926005789\\\/en\\\/1160297\\\/21\\\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220926005789\\\/en\\\/1160297\\\/21\\\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/","og_locale":"en_US","og_type":"article","og_title":"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call - Pharma Trend","og_description":"NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) announced today that it has scheduled the broadcast of the company\u2019s third quarter earnings conference call over the Internet on Wednesday, October 26, 2022 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer, William Grogan will discuss the company\u2019s third ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-26T20:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220926005789\/en\/1160297\/21\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call","datePublished":"2022-09-26T20:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/"},"wordCount":398,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220926005789\/en\/1160297\/21\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/","url":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/","name":"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220926005789\/en\/1160297\/21\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg","datePublished":"2022-09-26T20:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220926005789\/en\/1160297\/21\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220926005789\/en\/1160297\/21\/IDEX_Tagline_Blue_Stacked_Square_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/idex-corporation-to-webcast-third-quarter-2022-earnings-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"IDEX Corporation to Webcast Third Quarter 2022 Earnings Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48831"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48831\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}